Dermatological Aspects of COVID-19
On 31 December 2019, Wuhan, the capital city of Hubei Province in China reported World Health Organization(WHO) about cases of pneumonia which were caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) currently designated coronavirus disease (COVID-19). The infection rapidly spre...
Main Author: | Alina Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Lumbini Medical College
2020-06-01
|
Series: | Journal of Lumbini Medical College |
Subjects: | |
Online Access: | https://jlmc.edu.np/index.php/JLMC/article/view/379 |
Similar Items
-
Dermatological Manifestations in COVID-19 Disease
by: Öner Özdemir, et al.
Published: (2021-03-01) -
A cross-sectional survey to evaluate the influence of the COVID-19 pandemic on treatment adherence in chronic dermatological diseases
by: Priyanka C Patil, et al.
Published: (2023-01-01) -
Cutaneous manifestations associated with COVID-19: summary of current knowledge
by: Magdalena Jung, et al.
Published: (2024-02-01) -
Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
by: Carmen Rodriguez-Cerdeira, et al.
Published: (2021-01-01) -
A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals
by: Tassahil Messas, et al.
Published: (2023-06-01)